Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

July 01, 1984; Volume 26,Issue 1
  • You have access
    Two affinity states of Ri adenosine receptors in brain membranes. Analysis of guanine nucleotide and temperature effects on radioligand binding.
    M J Lohse, V Lenschow and U Schwabe
    Molecular Pharmacology July 1984, 26 (1) 1-9;
  • You have access
    Multiple states of the 5-hydroxytryptamine1 receptor as indicated by the effects of GTP on [3H]5-hydroxytryptamine binding in rat frontal cortex.
    M A Sills, B B Wolfe and A Frazer
    Molecular Pharmacology July 1984, 26 (1) 10-18;
  • You have access
    Theoretical structure-activity studies of benzodiazepine analogues. Requirements for receptor affinity and activity.
    G H Loew, J R Nienow and M Poulsen
    Molecular Pharmacology July 1984, 26 (1) 19-34;
  • You have access
    [3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites.
    J A Javitch, R O Blaustein and S H Snyder
    Molecular Pharmacology July 1984, 26 (1) 35-44;
  • You have access
    Structural requirements and species specificity of the inhibition by beta-endorphin of heavy acetylcholinesterase from vertebrate skeletal muscle.
    L W Haynes, M E Smith and C H Li
    Molecular Pharmacology July 1984, 26 (1) 45-50;
  • You have access
    Acute elevation of cyclic AMP does not alter the ion-conducting properties of the neuronal nicotinic acetylcholine receptor of PC12 cells.
    R McGee and B Liepe
    Molecular Pharmacology July 1984, 26 (1) 51-56;
  • You have access
    Interaction of a fluorescent acyldicholine with the nicotinic acetylcholine receptor and acetylcholinesterase.
    M B Bolger, V Dionne, J Chrivia, D A Johnson and P Taylor
    Molecular Pharmacology July 1984, 26 (1) 57-69;
  • You have access
    The interaction of sea anemone and scorpion neurotoxins with tetrodotoxin-resistant Na+ channels in rat myoblasts. A comparison with Na+ channels in other excitable and non-excitable cells.
    C Frelin, P Vigne, H Schweitz and M Lazdunski
    Molecular Pharmacology July 1984, 26 (1) 70-74;
  • You have access
    Activation of calmodulin by various metal cations as a function of ionic radius.
    S H Chao, Y Suzuki, J R Zysk and W Y Cheung
    Molecular Pharmacology July 1984, 26 (1) 75-82;
  • You have access
    Membrane-disordering potency and anticonvulsant action of valproic acid and other short-chain fatty acids.
    B J Perlman and D B Goldstein
    Molecular Pharmacology July 1984, 26 (1) 83-89;
  • You have access
    Cytosolic receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin. Evidence for a homologous nature among various mammalian species.
    T A Gasiewicz and G Rucci
    Molecular Pharmacology July 1984, 26 (1) 90-98;
  • You have access
    The interaction of the phosphorothioate insecticides chlorpyrifos and parathion and their oxygen analogues with bovine serum albumin.
    L G Sultatos, K M Basker, M Shao and S D Murphy
    Molecular Pharmacology July 1984, 26 (1) 99-104;
  • You have access
    DT-diaphorase and peroxidase influence the covalent binding of the metabolites of phenol, the major metabolite of benzene.
    R C Smart and V G Zannoni
    Molecular Pharmacology July 1984, 26 (1) 105-111;
  • You have access
    Free radicals in vivo. Covalent binding to lipids.
    C V Smith, H Hughes and J R Mitchell
    Molecular Pharmacology July 1984, 26 (1) 112-116;
  • You have access
    Structural gene products of the Ah locus. Transcriptional regulation of cytochrome P1-450 and P3-450 mRNA levels by 3-methylcholanthrene.
    F J Gonzalez, R H Tukey and D W Nebert
    Molecular Pharmacology July 1984, 26 (1) 117-121;
  • You have access
    Increased biliary GSSG efflux from rat livers perfused with thiocarbamide substrates for the flavin-containing monooxygenase.
    P A Krieter, D M Ziegler, K E Hill and R F Burk
    Molecular Pharmacology July 1984, 26 (1) 122-127;
  • You have access
    Effects of 1-beta-D-arabinofuranosylcytosine incorporation on eukaryotic DNA template function.
    D W Kufe, D Munroe, D Herrick, E Egan and D Spriggs
    Molecular Pharmacology July 1984, 26 (1) 128-134;
  • You have access
    Lethality associated with incorporation of 5-fluorouracil into preribosomal RNA.
    D Herrick and D W Kufe
    Molecular Pharmacology July 1984, 26 (1) 135-140;
  • You have access
    Relationship between activation and phosphorylation of tyrosine hydroxylase by 56 mm K+ in PC12 cells in culture.
    N Yanagihara, A W Tank and N Weiner
    Molecular Pharmacology July 1984, 26 (1) 141-147;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 26, Issue 1
1 Jul 1984
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics